arrow
A

Abigail K. Suwala

German Cancer Consortium
H指数:23
被引数:2,156

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

通过扩展的基于DNA甲基化的分类来推进CNS肿瘤诊断

2025-12-040
OAAI
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas

全球DNA高甲基化丢失是IDH突变型和1p/19q共缺失型少突胶质细胞瘤的预后指标。

2025-11-260
OAAI
Hetairos enables AI-based histopathological classification of CNS tumours

Hetairos 实现了基于 AI 的 CNS 肿瘤组织病理学分类

2025-11-010
OAAI
THE RECURRENT TISSUE STATES ACROSS ADULT GLIOMAS AS REVEALED BY SPATIAL TRANSCRIPTOMICS

由空间转录组学揭示的成人胶质瘤中的循环组织状态

2025-10-010
OAAI
AI-BASED HISTOPATHOLOGICAL CLASSIFICATION OF CENTRAL NERVOUS SYSTEM TUMOURS

基于人工智能的中央神经系统肿瘤组织病理学分类

2025-10-010
OAAI
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomas

对被诊断为粘液乳头型室管膜瘤的肿瘤谱系进行扩展

2025-09-300
OA
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis

TERT启动子突变对预测脑膜瘤预后的影响:一项多中心队列分析

2025-09-010
PRE
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

少突胶质细胞瘤,IDH突变型,1p/19q共缺失和TERTp野生型的独特分子特征与预后:是年轻患者的1级少突胶质细胞瘤?

2025-08-010
PRE
Outcome-associated factors in a molecularly defined cohort of central neurocytoma

分子定义的中央神经细胞瘤队列中的预后相关因素

2025-06-110
OAAI
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread

IDH-mutant astrocytomas伴原始神经元成分具有独特的甲基化谱和更高的软脑膜播散风险

2025-02-030
OA
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection

欧洲神经肿瘤学协会脑膜瘤靶向治疗分子检测指南

2024-11-230
OAAI
FINAL RESULTS FROM N2M2/NOA-20

N2M2/NOA-20的最终结果

2024-11-110
PRE